Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Clasificación en acciones #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Precio por acción
$11.14
Última sincronización: 2023-11-28
Capitalización bursátil
$160.14M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Monterey Bio Acquisition Corporation (MTRY)
Ganancias de Monterey Bio Acquisition Corporation (MTRY)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Monterey Bio Acquisition Corporation, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Monterey Bio Acquisition Corporation desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras